pyrazines has been researched along with deoxyglucose in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (23.08) | 18.7374 |
1990's | 5 (38.46) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (30.77) | 24.3611 |
2020's | 1 (7.69) | 2.80 |
Authors | Studies |
---|---|
Essig, A; Hong, CD | 1 |
Cornford, EM | 1 |
Grome, JJ; Harper, AM | 1 |
Fazio, F; Landoni, C; Lucignani, G; Monti, LD; Moresco, RM; Piatti, P; Pozza, G; Stefani, I | 1 |
Bergman, J; Haaparanta, M; Härkönen, R; Hartiala, J; Knuuti, MJ; Mäki, M; Nuutila, P; Ruotsalainen, U; Teräs, M; Voipio-Pulkki, LM; Wegelius, U; Yki-Järvinen, H | 1 |
Bax, JJ; Cornel, JH; Heine, RJ; van Lingen, A; Veening, MA; Visser, CA; Visser, FC | 1 |
Bax, JJ; Cornel, JH; Fioretti, PM; Krenning, EP; Poldermans, D; Rambaldi, R; Valkema, R; van Lingen, A; Visser, FC | 1 |
Gasser, R; Grisold, M; Köppel, H | 1 |
Kishimoto, M; Noda, M | 1 |
Ando, K; Irako, T; Nishimura, R; Sakamoto, M; Tsujino, D; Utsunomiya, K | 1 |
Araki, E; Furukawa, N; Goto, R; Ichimori, S; Iwashita, S; Kawashima, J; Kondo, T; Maeda, T; Matsumura, T; Matsuo, T; Matsuo, Y; Motoshima, H; Nishida, K; Sekigami, T; Shimoda, S | 1 |
Kawata, T; Matsubara, F; Nagai, Y; Nakamura, Y; Ohshige, T; Ohta, A; Sakai, K; Tanaka, Y; Tenjin, A; Terashima, Y; Tsukiyama, S | 1 |
Kulkarni, P; Padmanabhan, S | 1 |
1 review(s) available for pyrazines and deoxyglucose
Article | Year |
---|---|
FDG SPECT in the assessment of myocardial viability. Comparison with dobutamine echo.
Topics: Cardiotonic Agents; Deoxyglucose; Dobutamine; Echocardiography; Exercise Test; Fluorodeoxyglucose F18; Glucose; Humans; Hypolipidemic Agents; Myocardial Contraction; Myocardial Infarction; Myocardial Reperfusion; Myocardium; Predictive Value of Tests; Pyrazines; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 1997 |
4 trial(s) available for pyrazines and deoxyglucose
Article | Year |
---|---|
Myocardial glucose uptake evaluated by positron emission tomography and fluorodeoxyglucose during hyperglycemic clamp in IDDM patients. Role of free fatty acid and insulin levels.
Topics: Adult; Biological Transport, Active; Deoxyglucose; Diabetes Mellitus, Type 1; Fat Emulsions, Intravenous; Fatty Acids, Nonesterified; Fluorodeoxyglucose F18; Glucose; Glucose Clamp Technique; Humans; Hypolipidemic Agents; Insulin; Male; Myocardium; Pyrazines; Somatostatin; Tomography, Emission-Computed | 1995 |
Comparison of vildagliptin twice daily vs. sitagliptin once daily using continuous glucose monitoring (CGM): crossover pilot study (J-VICTORIA study).
Topics: Adamantane; Adult; Aged; Biomarkers; Blood Glucose; C-Peptide; Cross-Over Studies; Deoxyglucose; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Administration Schedule; Female; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Japan; Male; Middle Aged; Monitoring, Ambulatory; Natriuretic Peptide, Brain; Nitriles; Pilot Projects; Plasminogen Activator Inhibitor 1; Postprandial Period; Predictive Value of Tests; Pyrazines; Pyrrolidines; Serum Albumin; Sitagliptin Phosphate; Time Factors; Treatment Outcome; Triazoles; Vildagliptin | 2012 |
Efficacy and safety of sitagliptin as add-on therapy on glycemic control and blood glucose fluctuation in Japanese type 2 diabetes subjects ongoing with multiple daily insulin injections therapy.
Topics: Aged; Asian People; Blood Glucose; Blood Glucose Self-Monitoring; Body Mass Index; Deoxyglucose; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Female; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Male; Middle Aged; Pyrazines; Sitagliptin Phosphate; Triazoles | 2013 |
Comparison of the hypoglycemic effect of sitagliptin versus the combination of mitiglinide and voglibose in drug-naïve Japanese patients with type 2 diabetes.
Topics: Aged; Asian People; Blood Glucose; Cross-Over Studies; Deoxyglucose; Diabetes Mellitus, Type 2; Drug Combinations; Female; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Hypoglycemic Agents; Inositol; Insulin; Isoindoles; Male; Middle Aged; Pyrazines; Serum Albumin; Sitagliptin Phosphate; Triazoles | 2013 |
8 other study(ies) available for pyrazines and deoxyglucose
Article | Year |
---|---|
Effects of 2-deoxy-D-glucose, amiloride, vasopressin, and ouabain on active conductance and ENa in the toad bladder.
Topics: Amiloride; Animals; Biological Transport, Active; Bufo marinus; Deoxy Sugars; Deoxyglucose; Female; Membrane Potentials; Ouabain; Pyrazines; Sodium; Urinary Bladder; Vasopressins | 1976 |
Oltipraz-induced reduction in schistosomal glucose utilization rates.
Topics: Animals; Deoxyglucose; Female; Glucose; Male; Phosphorylation; Pyrazines; Schistosoma mansoni; Schistosomicides; Thiones; Thiophenes | 1988 |
Local cerebral glucose utilisation following indoleamine- and piperazine-containing 5-hydroxytryptamine agonists.
Topics: Animals; Autoradiography; Behavior, Animal; Brain; Deoxyglucose; Glucose; Guinea Pigs; Lysergic Acid Diethylamide; Male; Methoxydimethyltryptamines; Pyrazines; Quinolines; Quipazine; Rats; Rats, Inbred Strains; Receptors, Serotonin; Serotonin | 1986 |
Enhancement of myocardial [fluorine-18]fluorodeoxyglucose uptake by a nicotinic acid derivative.
Topics: Adult; Aged; Coronary Angiography; Deoxyglucose; Diabetes Mellitus, Type 2; Echocardiography; Female; Fluorodeoxyglucose F18; Glucose; Glucose Clamp Technique; Heart; Humans; Male; Middle Aged; Myocardial Infarction; Myocardium; Nicotinic Acids; Pyrazines; Radionuclide Ventriculography; Tomography, Emission-Computed | 1994 |
Optimal metabolic conditions during fluorine-18 fluorodeoxyglucose imaging; a comparative study using different protocols.
Topics: Aged; Blood Glucose; Coronary Disease; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose Clamp Technique; Glucose Tolerance Test; Heart; Humans; Hypolipidemic Agents; Male; Middle Aged; Pyrazines; Tomography, Emission-Computed, Single-Photon | 1997 |
First description of the effect of a non-sulfonylurea compound, tetramethylpyrazine, on coronary response to desoxyglucose-induced ischemia.
Topics: Adenosine Triphosphate; Animals; Coronary Circulation; Deoxyglucose; Flavoring Agents; Guinea Pigs; Myocardial Ischemia; Organ Culture Techniques; Perfusion; Potassium Channels; Pyrazines; Sweetening Agents; Vasodilation | 1998 |
A pilot study of the efficacy of miglitol and sitagliptin for type 2 diabetes with a continuous glucose monitoring system and incretin-related markers.
Topics: 1-Deoxynojirimycin; Aged; Biomarkers; Blood Glucose; Case-Control Studies; Deoxyglucose; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glycoside Hydrolase Inhibitors; Humans; Hyperglycemia; Hypoglycemic Agents; Incretins; Insulin; Male; Middle Aged; Monitoring, Physiologic; Pilot Projects; Postprandial Period; Pyrazines; Sitagliptin Phosphate; Triazoles | 2011 |
A novel property of hexokinase inhibition by Favipiravir and proposed advantages over Molnupiravir and 2 Deoxy D glucose in treating COVID-19.
Topics: Amides; Antiviral Agents; COVID-19 Drug Treatment; Cytidine; Deoxyglucose; Hexokinase; Humans; Hydroxylamines; Molecular Docking Simulation; Pyrazines; SARS-CoV-2 | 2022 |